Puyang Hotway Pharmaceuticals Co.,Ltd.

Puyang Hotway Pharmaceuticals CO., Ltd. was established in September, 1997 .The registered capital of Hotway is 50.63 million Yuan and it covers an area of 44,666 ㎡. Hotway has passed the GMP acceptance of antibiotic API workshop, premix workshop of MOA in 1998, and was the first Veterinary drug API manufacturing enterprise to pass the GMP acceptance of MOA of China . Hotway is a national high-tech enterprise integrating the research, development, production and sales of veterinary antibiotic API, feed additives and animal health products. The existing production lines include antibiotic API ,Premix and Powder, etc. The main products are Maduramicin ammonium API, Ampramycin sulfate API ,Premix and Powder for poultry ,etc.. Hotway has established a long-term cooperative relation with American Zoetis for series products of Maduramicin ammonium ,the products are exported to dozens of countries and regions, and have won the favor and praise of customers for their high quality. The animal-specific antibiotic Apramycin sulfate researched and developed by Hotway and Chinese Academy of Sciences is a second-class new veterinary drug, and its production, sales and brand awareness are among the best in China and abroad. Hotway has established R﹠D platforms such as Puyang veterinary medicine engineering technology research center, Puyang key laboratory, Henan feed additive engineering technology center, Henan provincial enterprise technology center and Henan Hotway pharmaceutical academician workstation, etc.. Hotway has undertaken a number of national, provincial and municipal scientific and technological research and industrialization projects, and obtained a number of patents.